The global digital diabetes management market size is expected to reach USD 21.9 billion by 2030, expanding at a CAGR of 8.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. Major factors contributing to the market growth are the growing incidences of diabetes globally, the increasing number of product launches, and innovation in technologies such as predictive analytics and artificial intelligence (AI).
Data analytics and artificial intelligence are now an integral part of digital solutions for diabetics. AI is gaining rapid attention due to its ability to harness massive volumes of patient information. Digital diabetes management tools help patients analyze their glucose levels and pattern. They also help patients decide on food intake and dosage of insulin. The number of smartphone apps for disease management has seen a monumental rise over the past few years, giving the market a major boost. For instance, in September 2019, Abbott entered into a non-exclusive partnership with Sanofi to integrate cloud-connected insulin pens (Sanofi) with FreeStyle Libre mobile application (Abbott) to ease the management process of diabetes.
Gather more insights about the market drivers, restrains and growth of the Digital Diabetes Management Market
Detailed Segmentation:
Product Insights
The continuous blood glucose monitoring system segment held the largest revenue share of over 40.6% in 2022, owing to its advanced features such as compatibility with smart devices that serve as display devices. Moreover, it can be set to send custom alerts to patients when certain glucose thresholds are reached. Based on products, the market has been segmented into smart insulin pens, continuous blood glucose monitoring systems, smart glucose meters, smart insulin pumps, and apps. Diabetes management apps are divided into digital diabetes management apps and weight & diet management apps.
End-use Insights
Based on end-use, the digital diabetes management market is segmented into hospitals, home settings, and diagnostic centers. Hospitals can use digital platforms or mobile apps that provide diabetes education, self-management tools, and support, as well as offer them to patients. With these technologies, patients may better understand their condition, monitor their blood sugar levels, take control of their medication, and get advice from medical specialists.
Type Insights
The wearable devices segment held the largest revenue share of 56.9% in 2022, and the segment is expected to expand at the fastest CAGR of 8.4% over the forecast period. The segment's growth is majorly attributed to technological advancements such as the advent of artificial intelligence, the launch of new products such as closed-loop pump systems and smart insulin patches, and the growing adoption of self-insulin delivery devices in diabetes management. The market is segmented based on type into wearable devices and handheld devices.
Regional Insights
North America led the market in 2022 with a revenue share of over 38.0%, aided by the availability of advanced technologies and the recent approval of many digital blood glucose patient monitoring devices in the region. For instance, in January 2022, Insulet Corporation announced that it had received clearance from the U.S. FDA for its Omnipod 5 Automated Insulin Delivery System. It is a unique system that integrates with Dexcom G6 Continuous Glucose Monitoring (CGM). It facilitates remote patient monitoring and data transfer through the Omnipod 5 mobile app with its integrated SmartBolus Calculator. The increasing geriatric population and the growing burden of diabetes due to lifestyle changes are expected to boost regional market growth.
Browse through Grand View Research's Medical Devices Industry Research Reports.
• The global artificial hip and knee joints market size was estimated at USD 12.57 billion in 2023 and is projected to grow at a CAGR of 2.85% from 2024 to 2030.
• The global breast shells market size was valued at USD 71.0 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2030.
Key Companies & Market Share Insights
Major market players focus on adopting new technologies and introducing advanced products, taking advantage of important cooperation activities, and exploring acquisitions and government initiatives to offer their customers better services and strengthen their market presence. For instance, in August 2022, Abbott Laboratories announced its collaboration with WeightWatchers to launch new digital tools to emphasize the importance of weight loss and controlling blood sugar in diabetes patients. Abbott integrated its recent digital glucose monitoring technology into WeightWatchers' diabetes-specific program, as a part of this strategic partnership.
In another instance, in May 2021, Ascensia Diabetes Care launched a browser-based diabetes management and analytics platform, GlucoContro.online, that provides data-driven care for people who use any of the CONTOUR blood glucose monitoring meters. In September 2021, Ypsomed AG partnered with Dexcom, a market leader in CGM systems. This partnership was intended to make data from Dexcom G6 CGM devices available in the Ypsomed application in a smart device.
Following are some of the major participants in the global digital diabetes management market:
• Abbott
• Medtronic
• F. Hoffmann-La Roche Ltd.
• Bayer AG
• Sanofi
• Dexcom, Inc.
• LifeScan, Inc.
• Insulet Corporation
• Ascensia Diabetes Care Holdings AG
• B. Braun Melsungen AG
Digital Diabetes Management Market Segmentation
Grand View Research has segmented the global digital diabetes management market based on product, type, end-use, and region:
Digital Diabetes Management Product Outlook (Revenue, USD Million, 2018 - 2030)
• Smart Glucose Meter
• Continuous Blood Glucose Monitoring System
• Smart Insulin Pens
• Smart Insulin Pumps
• Apps
o Digital Diabetes Management Apps
o Weight & Diet Management Apps
Digital Diabetes Management Type Outlook (Revenue, USD Million, 2018 - 2030)
• Wearable Devices
• Handheld Devices
Digital Diabetes Management End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Home settings
• Diagnostic centers
Digital Diabetes Management Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Sweden
o Norway
o Denmark
• Asia Pacific
o Japan
o China
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East & Africa
o South Africa
o Saudi Arabia
o UAE
o Kuwait
Order a free sample PDF of the Digital Diabetes Management Market Intelligence Study, published by Grand View Research.